Trial
NCT00288353
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
National Alliance for Research on Schizophrenia and Depression
Condition
Schizophrenia
Intervention
aripiprazole (Abilify)
Why stopped
unable to secure additional funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-02